S. Zeybek Et Al. , "Evaluation of the effect of botulinum neurotoxin type A (BoNT/A) on daily activity performance in chronic migraine patients using VAS, MIDAS AND HIT-6 tests," Neurology Asia , vol.23, no.1, pp.35-43, 2018
Zeybek, S. Et Al. 2018. Evaluation of the effect of botulinum neurotoxin type A (BoNT/A) on daily activity performance in chronic migraine patients using VAS, MIDAS AND HIT-6 tests. Neurology Asia , vol.23, no.1 , 35-43.
Zeybek, S., Kisabay, A., Sari, U. S., & Selcuki, D., (2018). Evaluation of the effect of botulinum neurotoxin type A (BoNT/A) on daily activity performance in chronic migraine patients using VAS, MIDAS AND HIT-6 tests. Neurology Asia , vol.23, no.1, 35-43.
Zeybek, Sinem Et Al. "Evaluation of the effect of botulinum neurotoxin type A (BoNT/A) on daily activity performance in chronic migraine patients using VAS, MIDAS AND HIT-6 tests," Neurology Asia , vol.23, no.1, 35-43, 2018
Zeybek, Sinem Et Al. "Evaluation of the effect of botulinum neurotoxin type A (BoNT/A) on daily activity performance in chronic migraine patients using VAS, MIDAS AND HIT-6 tests." Neurology Asia , vol.23, no.1, pp.35-43, 2018
Zeybek, S. Et Al. (2018) . "Evaluation of the effect of botulinum neurotoxin type A (BoNT/A) on daily activity performance in chronic migraine patients using VAS, MIDAS AND HIT-6 tests." Neurology Asia , vol.23, no.1, pp.35-43.
@article{article, author={Sinem Zeybek Et Al. }, title={Evaluation of the effect of botulinum neurotoxin type A (BoNT/A) on daily activity performance in chronic migraine patients using VAS, MIDAS AND HIT-6 tests}, journal={Neurology Asia}, year=2018, pages={35-43} }